Product Description
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Topical, Oral
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Takeda
Company Location: Asia Pacific
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 1: Friedreich Ataxia
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT07318129 |
iPROACT-MS | N/A |
Not yet recruiting |
Multiple Sclerosis, Relapsing-Remitting |
2028-07-15 |
2026-01-06 |
||
NCT07105514 |
iPROACT-pilot2 | N/A |
Recruiting |
Inflammation|Brain Diseases, Metabolic|Type 2 Diabetes |
2025-10-30 |
2025-08-13 |
||
NCT06674018 |
iPROACT-pilot | N/A |
Completed |
Type 2 Diabetes|Inflammation|Brain Diseases, Metabolic |
2025-02-25 |
2025-02-28 |
||
NCT01898884 |
NCT01898884 | P1 |
Completed |
Friedreich Ataxia |
2015-06-18 |
2025-08-27 |
Primary Endpoints |
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
04/28/2024 |
PubMed |
Serum metabolomic profiling of patients with liver cirrhosis at different stages. |
|
05/09/2024 |
PubMed |
Decreased circulating IPA levels identify subjects with metabolic comorbidities: A multi-omics study. |
|
05/08/2024 |
PubMed |
One size might fit all: Indole-3-propionic acid potentiates pan-cancer immunotherapy. |
|
09/14/2023 |
News Article |
Abu Dhabi The Destination of Choice for Global Players With ADGM's Record-Breaking Numbers for First Half of 2023 |
|
09/14/2023 |
News Article |
Montauk Brewing Expands Distribution Beyond the Northeast |
|
09/14/2023 |
News Article |
IPA Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2024 |
|
09/14/2023 |
News Article |
InMobi Forges Global Partnership with Ad Net Zero to Further its Commitment to Sustainable Advertising Practices |